Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NDUFS8 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RPRM | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | DESI2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | VPS4B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | STXBP5L | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | XRCC6 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | GPR63 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ACTL6B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | STBD1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | KIAA0922 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |